Cite
HARVARD Citation
Lai, Y. et al. (2022). An open‐label, multicenter, efficacy, and safety study of deferasirox in iron‐overloaded patients with non‐transfusion‐dependent thalassemia (THETIS): 5‐year results. American journal of hematology. 97 (8), pp. E281-E284. [Online].